D-Wave Quantum stock slides into weekend after sharp swing; QBTS investors eye late-January deal timeline

D-Wave Quantum stock slides into weekend after sharp swing; QBTS investors eye late-January deal timeline

New York, Jan 10, 2026, 19:29 EST — The market has closed for the day.

  • D-Wave Quantum shares dropped 4.0% on Friday, closing at $28.11 after fluctuating between $28.07 and $31.13 during the session.
  • On Saturday, MarketBeat reported that Wall Street Zen upgraded its rating on D-Wave to “hold.”
  • Investors await updates on D-Wave’s planned acquisition of Quantum Circuits, with a timeline set for late January.

D-Wave Quantum Inc shares ended Friday down 4.0%, closing at $28.11 after a choppy session. Investors now turn to next week for updates on the company’s growth strategy.

This move is significant now because D-Wave has turned into a fast-money favorite once more. Even minor changes in expectations can pack a punch when investors juggle execution risks alongside lofty promises in a developing technology.

U.S. markets are closed for the weekend, shifting attention to Monday’s open and the potential impact of Wall Street Zen’s recent rating update on D-Wave. The research service upgraded its rating to “hold,” as reported by MarketBeat on Saturday. (MarketBeat)

D-Wave announced earlier this week its plan to acquire Quantum Circuits for $550 million — with $300 million paid in D-Wave stock and $250 million in cash — as it aims to expand into “gate-model” quantum machines. This approach is broader than the company’s traditional “annealing” systems, which focus mainly on optimization tasks. CEO Alan Baratz said the deal will accelerate the launch of “gate-model products and services” by 2026. (D-Wave Quantum)

A securities filing revealed the merger agreement was signed on Jan. 6, maintaining the same stock-and-cash structure. The share portion is linked to the closing value and comes with adjustments detailed in the agreement. The filing also outlined lock-up terms for certain stock allocated to key employees. (SEC)

D-Wave is setting the stage for longer-term growth. The company posted $3.7 million in revenue for Q3 fiscal 2025, alongside a net loss of $140 million. That loss was mainly due to non-cash charges related to warrant accounting. As of September 30, 2025, D-Wave held $836.2 million in consolidated cash. (SEC)

Peer news came in mixed, fueling the sector’s volatile trading. Rigetti Computing announced Friday it now expects its 108-qubit system to reach general availability near the end of Q1 2026. CEO Subodh Kulkarni said the company is dedicating extra time to fine-tune and test the performance. (Stock Titan)

D-Wave faces a clear risk: the Quantum Circuits deal hinges on closing conditions. Their own presentations warn that forward-looking targets may fall short if technical challenges arise or deadlines are pushed back. (SEC)

Investors should mark late January on their calendars. That’s when D-Wave anticipates finalizing the acquisition. Shortly after, on Jan. 27-28, the company will host its Qubits 2026 user conference in Boca Raton, Florida. This event usually showcases new product strategies and customer applications. (D-Wave Quantum)

Stock Market Today

  • Gilead Sciences priced for upside after 38.5% one-year gain, DCF signals undervaluation
    January 11, 2026, 11:55 AM EST. GILD traded near $121.10, up 0.6% in 30 days and 38.5% over the past year. The stock's longer-term returns-56.0% over three years and 131.7% over five-frame questions about risk and upside as investors reassess pipelines, approvals and competitive pressures in biopharma. A valuation check assigns Gilead Sciences a 5 out of 6 score, then three methods show divergent views. A two-stage free cash flow to equity model yields an intrinsic value around $274.50 per share, implying the stock is about 55.9% undervalued vs $121.10. The P/E stands at 18.53x, modest versus some biotech peers, underscoring how growth expectations and risk shape multiples. Overall, the model suggests meaningful upside from current levels.
Netflix stock slips on Warner Bros deal drama — earnings is the next test
Previous Story

Netflix stock slips on Warner Bros deal drama — earnings is the next test

Compass stock jumps after Anywhere merger closes and $1 billion note deal — what to watch Monday
Next Story

Compass stock jumps after Anywhere merger closes and $1 billion note deal — what to watch Monday

Go toTop